Scholars@Duke

The economics of the hematopoietic growth factors.

Publication ,  Journal Article
Eldar-Lissai, A; Lyman, GH
Published in: Cancer Treat Res
2011
Published version (DOI) Link to item

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

Cancer Treat Res

DOI

10.1007/978-1-4419-7073-2_22

ISSN

0927-3042

Publication Date

2011

Volume

157

Start / End Page

403 / 418

Location

United States

Related Subject Headings

  • Humans
  • Hematopoietic Cell Growth Factors
  • Hematopoiesis
  • Cost-Benefit Analysis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Eldar-Lissai, A., & Lyman, G. H. (2011). The economics of the hematopoietic growth factors. Cancer Treat Res, 157, 403–418. https://doi.org/10.1007/978-1-4419-7073-2_22
Eldar-Lissai, Adi, and Gary H. Lyman. “The economics of the hematopoietic growth factors.” Cancer Treat Res 157 (2011): 403–18. https://doi.org/10.1007/978-1-4419-7073-2_22.
Eldar-Lissai A, Lyman GH. The economics of the hematopoietic growth factors. Cancer Treat Res. 2011;157:403–18.
Eldar-Lissai, Adi, and Gary H. Lyman. “The economics of the hematopoietic growth factors.” Cancer Treat Res, vol. 157, 2011, pp. 403–18. Pubmed, doi:10.1007/978-1-4419-7073-2_22.
Eldar-Lissai A, Lyman GH. The economics of the hematopoietic growth factors. Cancer Treat Res. 2011;157:403–418.

Published In

Cancer Treat Res

DOI

10.1007/978-1-4419-7073-2_22

ISSN

0927-3042

Publication Date

2011

Volume

157

Start / End Page

403 / 418

Location

United States

Related Subject Headings

  • Humans
  • Hematopoietic Cell Growth Factors
  • Hematopoiesis
  • Cost-Benefit Analysis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis